Poor Sleep
Sanofi India Limited and Cipla Limited have announced an exclusive partnership for distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India. As a part of this partnership, Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium®, a leading brand in the anti-epileptic medication category.
While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India and internationally, Cipla will leverage its capabilities and robust India-wide network of strong marketing and sales professionals, distributors, institutions, and market outreach programs to expand access to these treatments for patients who need them.
One of the biggest economic burdens caused by air pollution is healthcare expenses. Polluted air…
Union health minister JP Nadda on Tuesday chaired the ninth meeting of Mission Steering Group…
On the occasion of World Obesity Day, the All India Institute of Medical Sciences (AIIMS)…
Nowadays, there are several things in our kitchen that are slowly harming our health and…
Walking always benefits and is one of the best exercises. But do you know that…
Every year on March 3 is observed as World Hearing Day to raise awareness about…